T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
United Therapeutics
UTHR
$18B
| $123M | 0.01% |
344,527
+109,611
| +47% | +$39.3M |
|
527
Sprouts Farmers Market
SFM
$13B
| $120M | 0.01% |
1,088,091
-237
| -0% | -$26.2K |
|
528
Summit Therapeutics
SMMT
$13B
| $119M | 0.01% |
5,439,657
+3,397,557
| +166% | +$74.4M |
|
529
Kilroy Realty
KRC
$4.98B
| $119M | 0.01% |
3,072,096
-245,568
| -7% | -$9.5M |
|
530
Confluent
CFLT
$6.85B
| $119M | 0.01% |
5,829,069
-11,124,418
| -66% | -$227M |
|
531
NiSource
NI
$19.1B
| $118M | 0.01% |
3,413,585
-2,991,393
| -47% | -$104M |
|
|
SRCL
532
DELISTED
Stericycle Inc
SRCL
| $118M | 0.01% |
1,933,403
-38,112
| -2% | -$2.32M |
|
533
Onto Innovation
ONTO
$5.24B
| $117M | 0.01% |
564,012
-188,938
| -25% | -$39.2M |
|
534
Truist Financial
TFC
$58.1B
| $117M | 0.01% |
2,727,305
-361,422
| -12% | -$15.5M |
|
535
Murphy USA
MUSA
$7.27B
| $116M | 0.01% |
235,672
-10,461
| -4% | -$5.16M |
|
536
The Ensign Group
ENSG
$9.57B
| $115M | 0.01% |
801,617
-42,268
| -5% | -$6.08M |
|
537
Axon Enterprise
AXON
$58B
| $115M | 0.01% |
286,943
+14,955
| +5% | +$5.98M |
|
538
Oscar Health
OSCR
$4.9B
| $114M | 0.01% |
5,388,061
+431,626
| +9% | +$9.15M |
|
539
Capital One
COF
$142B
| $114M | 0.01% |
762,643
-52,770
| -6% | -$7.9M |
|
540
Liberty Media Series C
FWONK
$24.8B
| $113M | 0.01% |
1,457,907
+242,478
| +20% | +$18.8M |
|
|
SWTX
541
DELISTED
SpringWorks Therapeutics
SWTX
| $113M | 0.01% |
3,516,418
-85,816
| -2% | -$2.75M |
|
542
Zegna
ZGN
$2.26B
| $113M | 0.01% |
11,446,653
-1,556,805
| -12% | -$15.3M |
|
543
Monster Beverage
MNST
$61.3B
| $112M | 0.01% |
2,145,501
-43,258
| -2% | -$2.26M |
|
544
Nuvalent
NUVL
$5.62B
| $111M | 0.01% |
1,082,277
+328,139
| +44% | +$33.6M |
|
545
Wynn Resorts
WYNN
$12.8B
| $110M | 0.01% |
1,150,859
+155,113
| +16% | +$14.9M |
|
546
Fastenal
FAST
$54.9B
| $110M | 0.01% |
3,068,602
+84,924
| +3% | +$3.03M |
|
547
Ecolab
ECL
$76.1B
| $109M | 0.01% |
428,344
-346
| -0.1% | -$88.3K |
|
548
Akero Therapeutics
AKRO
$3.41B
| $109M | 0.01% |
3,808,359
-337,992
| -8% | -$9.7M |
|
549
Nutanix
NTNX
$20.5B
| $109M | 0.01% |
1,837,828
-441,743
| -19% | -$26.2M |
|
550
General Motors
GM
$54.5B
| $109M | 0.01% |
2,427,776
-3,973,021
| -62% | -$178M |
|